Eli Lilly to cut insulin prices by 70 percent

Pharmaceutical giant Eli Lilly is slashing prices of commonly prescribed insulin drugs by 70 percent while capping related out-of-pocket costs at $35 a month, a move that should help address long-standing concerns about the high cost of diabetes care. The cost of its non-branded insulin, Insulin Lispro Injection, is being cut to $25 per vial from a current…